Searchable abstracts of presentations at key conferences in endocrinology

ea0005p83 | Diabetes, Metabolism and Cardiovascular | BES2003

Testosterone is a dilator of resistance arteries in men with congestive heart failure

Malkin C , Pugh P , Jones R , Jones T , Channer K

BackgroundHeart failure is a syndrome of vaso-constriction and hormone abnormalities. There is an excess of catabolic and vasoconstrictor hormones and a relative deficiency of anabolic hormones. Vaso-dilating drugs improve symptoms in heart failure and inhibition of some catabolic / vasoconstrictor hormones improves prognosis. We aimed to study the direct vascular effects of testosterone resistance arteries from men with heart failure.Methods6 resistance arteries w...

ea0003p67 | Clinical Case Reports | BES2002

Seizures as first manifestation of catch 22 syndrome in adulthood

Nath U , Jones R , Chapman A

An 18 year old nursery nurse suffered two probable seizures. She was commenced on Phenytoin. She had had a cleft palate repair. Clinical examination revealed hypertelorism and short fourth metatarsals. Early papilloedema was noted. Routine blood tests showed profound hypocalcaemia of 1.2 mmol/l. Serum phosphate , magnesium and parathormone levels were normal. She suffered a further seizure and was given intravenous calcium. She suffered no further seizures and calcium levels w...

ea0009p19 | Diabetes and metabolism | BES2005

Cholesterol feeding induces fatty streak formation in the testicular feminised mouse

Nettleship J , Jones R , Channer K , Jones T

Introduction: Low endogenous testosterone is associated with atherosclerosis in elderly men. The aim of this study was to determine whether an inactive androgen receptor (AR) coupled with testosterone deficiency, inherent to the testicular feminised (Tfm) mouse, is associated with atherosclerosis following cholesterol feeding.Methods: Eight-week-old Tfm (n=34) and XY (n=32) littermate controls were fed for 16, 20, 24 or 28 weeks on either diet 1 (compris...

ea0009p33 | Diabetes and metabolism | BES2005

Testosterone does not promote A7r5 rat aortic vascular smooth muscle cell growth

Kerry K , Jones R , Channer K , Jones T

Vascular smooth muscle cells (VSMC) form a major constituent of the atherosclerotic plaque providing structural stability. However, increased cell number due to high proliferation rates can lead to greater artery occlusion. Testosterone replacement therapy improves exercise capacity and reduces symptoms of angina in men with coronary artery disease, although its effect upon VSMC growth is currently unknown. Testosterone deficiency is associated with increased atheroma burden a...

ea0009p35 | Diabetes and metabolism | BES2005

Study of the effect of testosterone upon apoptosis in the rat aortic A7r5 vascular smooth muscle cell line

Kerry K , Jones R , Channer K , Jones T

Several studies have demonstrated that atherosclerosis is associated with low serum levels of testosterone and replacement therapy reduces myocardial ischaemia in men. Vascular smooth muscle cell (VSMC) apoptosis reduces plaque stability. The role of testosterone if any, in this process is unknown. Testosterone has been demonstrated act via both the classic androgen receptor and by calcium channel antagonism. Calcium channel blockers have been shown to induce VSMC apoptosis. W...

ea0009p136 | Steroids | BES2005

Establishment of physiological and supra-physiological testosterone dosing regimen in mice

Nettleship J , Jones R , Channer K , Jones T

Objective: The aim of this study was to determine dosing regimen to replace testosterone to physiological levels in the testicular feminised (Tfm) mouse, and also to produce similar supraphysiological testosterone concentrations in Tfm and XY littermates.Methods: Eight-week-old Tfm (n=66) and XY littermate controls (n=24) received a single 10 microlitre intramuscular injection of testosterone (Sustanon 100 - 100 milligrams testosterone per litre, or Sust...

ea0007p36 | Diabetes, metabolism and cardiovascular | BES2004

A7r5 rat aortic vascular smooth muscle cell apoptosis is reduced by testosterone

Kerry K , Clark S , Jones R , Channer K , Jones T

Low testosterone levels in men are associated with increased atherosclerosis, and testosterone replacement therapy has been shown to reduce myocardial ischemia in men with coronary artery disease. Vascular smooth muscle cell (VSMC) apoptosis is proposed to reduce plaque stability, but the role of testosterone in this process is unknown. Testosterone causes vasodilatation via calcium channel antagonism and the calcium channel antagonist nifedipine induces VSMC apoptosis. We hav...

ea0007p37 | Diabetes, metabolism and cardiovascular | BES2004

Mitogen-induced apoptosis in A7r5 rat aortic vascular smooth muscle cells is not effected by testosterone

Kerry K , Clark S , Jones R , Channer K , Jones T

Atherosclerotic plaque smooth muscle cells (SMCs) are sensitive to apoptotic stimuli, increasing plaque instability. Testosterone replacement therapy is beneficial in men with coronary artery disease, although its effect upon plaque stability is unknown. We have utilised the rat A7r5 vascular SMC line to investigate the effects of testosterone on apoptosis induced by serum deprivation or the calcium channel antagonist nifedipine.Cells were plated at 1500...

ea0007p63 | Diabetes, metabolism and cardiovascular | BES2004

Testosterone inhibits Ca2+ currents in A7r5 vascular smooth muscle cells, and in HEK293 cells stably expressing the alpha1C subunit of L-type Ca2+ channels (CaV1.2) and alpha1H T-type Ca2+ channels (CaV3.2)

Scragg J , Jones R , Channer K , Jones T , Peers C

Testosterone reduces myocardial ischaemia in men with coronary artery disease (CAD) and improves symptoms and exercise capacity in men with congestive heart failure (CHF), effects proposed to be due to testosterone-induced vasodilatation. Isolated vessel studies suggest this occurs via a calcium antagonistic action upon voltage-gated Ca2+ channels but this has yet to be investigated directly.We therefore employed patch clamp methodology to stu...

ea0006p26 | Diabetes, metabolism and cardiovascular | SFE2003

The relationship between serum levels of testosterone and inflammatory cytokines in men wih coronary artery disease

Nettleship J , Jones R , Pugh P , Channer K , Jones T

Evidence supports a protective role for testosterone in men with coronary artery disease (CAD) and in the regulation of cytokine function. This study examined the relationship between serum levels of inflammatory cytokines and testosterone in men with CAD. Serum was collected from 69 men (59+1 years) having >75% occlusion of 1 (n=20), 2 (n=18) or 3 (n=31) coronary arteries. Levels of total testosterone (TT), bioavailable testosterone (BT), tumour necrosis factor-alpha (TNFa...